跳至主要内容
临床试验/NL-OMON47603
NL-OMON47603招募中不适用

The in vivo mechanisms that control migration of pathogenic dermal T-cells to synovial joints during psoriatic arthritis: the role of dermal lymphatic vessels. - T-cell migration from skin to joints in psoriatic arthritis.

Maasstadziekenhuis0 个研究点目标入组 101 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria psoriasis patients:
  • - patients that are diagnosed with psoriasis by their dermatologist
  • - age * 18 years
  • - written informed consent by the patient;Inclusion criteria psoriatic arthritis patients:
  • - Psoriasis patients that are diagnosed with psoriatic arthritis by their rheumatologist (according
  • to the CASPAR criteria)
  • - age * 18 years
  • - written informed consent by the patient;Inclusion criteria healthy volunteer:
  • - age * 18 years
  • - WHO performance score 0
  • - age and sex matched (for psoriasis and psoriatic arthritis)
  • - written informed consent ;Inclusion criteria systemic sclerosis patients:
  • - Patients that are diagnosed with systemic sclerosis by their rheumatologist
  • - age * 18 years
  • - written informed consent given by the patient;Inclusion criteria systemic lupus erythematodes patients:
  • - Patients that are diagnosed with systemic lupus erythematodes by their rheumatologist
  • - age * 18 years
  • - written informed consent given by the patient;Inclusion criteria vasculitis patients with skin involvement:
  • - Patients that are diagnosed with vasculitis by their rheumatologist
  • - age * 18 years
  • - written informed consent given by the patient;Human tissues;Inclusion criteria for tissue donors, ie. skin tissue: patients undergoing eyelid surgery; mammareduction/abdominoplasty; synovial tissue: knee-replacement therapy in PsA and osteoarthritis (orthopedic surgery), synovectomy wrist (plastic surgery)
  • - donors will be asked for their permission to use their materials anonymously; this will be recorded in their medical file.;Inclusion criteria for tissue donors, ie. patients undergoing vascular surgery. The 3 categories of vascular surgery patients that will be included are patients undergoing crossectomy in chronic venous insufficiency; carotid endarterectomy, and surgical bypass of aortoiliac occlusive disease in patients with intermittent claudicatio without any signs of infection or critical (limb) ischemia.
  • - written informed consent given by the patient

排除标准

  • - use of corticosteroids including topical or systemic for the last 6 weeks
  • - use of disease-modifying antirheumatic drugs (DMARDs) or immune-suppressive drugs
  • for the last 6 weeks
  • - concomitant use of drugs affecting the lymphatic system and/or immune responses
  • including non-steroidal anti-inflammatory drugs (NSAIDs), drugs targeting RAAS system,
  • and anti-allergy medication. These agents must be discontinued at least 6 weeks before
  • the screening visit.
  • - co-existence of chronic inflammatory disorders including eczema, asthma or chronic
  • - pregnancy
  • - active cancer
  • - any lymphatic, cardiovascular or immunodeficiency disorder

研究者

发起方
Maasstadziekenhuis

相似试验